Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.

Zobell JT, Young DC, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Jun;48(6):525-37. doi: 10.1002/ppul.22757. Epub 2013 Jan 28. Review.

PMID:
23359557
2.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.

Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Review.

PMID:
22949297
3.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.

Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K.

Pediatr Pulmonol. 2013 Mar;48(3):211-20. doi: 10.1002/ppul.22667. Epub 2012 Sep 4. Review.

PMID:
22949224
4.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems.

Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2012 Dec;47(12):1147-58. doi: 10.1002/ppul.22655. Epub 2012 Aug 21. Review.

PMID:
22911974
5.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.

Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Jan;48(1):1-7. doi: 10.1002/ppul.22664. Epub 2012 Sep 4.

PMID:
22949160
6.

Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Greally P, Whitaker P, Peckham D.

Curr Med Res Opin. 2012 Jun;28(6):1059-67. doi: 10.1185/03007995.2012.674500. Epub 2012 May 10. Review.

PMID:
22401602
7.

Oral anti-pseudomonal antibiotics for cystic fibrosis.

Remmington T, Jahnke N, Harkensee C.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005405. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD005405.

PMID:
17636796
8.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.

Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Nov;48(11):1047-61. doi: 10.1002/ppul.22813. Epub 2013 Sep 2. Review.

PMID:
24000183
9.

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

Ryan G, Mukhopadhyay S, Singh M.

Cochrane Database Syst Rev. 2003;(3):CD001021. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001021.

PMID:
12917897
10.

The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Banerjee D, Stableforth D.

Drugs. 2000 Nov;60(5):1053-64. Review.

PMID:
11129122
11.

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

Ryan G, Mukhopadhyay S, Singh M.

Cochrane Database Syst Rev. 2000;(2):CD001021. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD001021.

PMID:
10796732
12.

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

Döring G, Conway SP, Heijerman HG, Hodson ME, Høiby N, Smyth A, Touw DJ.

Eur Respir J. 2000 Oct;16(4):749-67. Review.

13.

Update on treatment of pulmonary exacerbations in cystic fibrosis.

Smyth A.

Curr Opin Pulm Med. 2006 Nov;12(6):440-4. Review.

PMID:
17053495
14.

Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients.

Zobell JT, Ferdinand C, Young DC.

Pediatr Pulmonol. 2014 Mar;49(3):302-6. doi: 10.1002/ppul.22820. Epub 2013 Jun 17.

PMID:
23775821
15.

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Ryan G, Jahnke N, Remmington T.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008319. doi: 10.1002/14651858.CD008319.pub2. Review.

PMID:
23235659
16.

A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients.

Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield BA.

Pediatr Pulmonol. 2011 Oct;46(10):987-90. doi: 10.1002/ppul.21467. Epub 2011 Apr 25.

PMID:
21520438
17.

Antibiotic use in cystic fibrosis.

Eisenberg JD.

Curr Opin Pulm Med. 1996 Nov;2(6):439-46. Review.

PMID:
9363182
18.
19.

The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.

Zobell JT, Kemper AL, Young DC.

Pediatr Pulmonol. 2014 Mar;49(3):E48-51. doi: 10.1002/ppul.22798. Epub 2013 May 9.

PMID:
23661625
20.

A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.

Prescott WA Jr.

Respir Care. 2014 Sep;59(9):1353-9. doi: 10.4187/respcare.02980. Epub 2014 Apr 29.

Supplemental Content

Support Center